Regression of melanoma, but not keratoacanthoma, is associated with increased HLA-B22 and decreased HLA-B27 and HLA-DR1

Citation
Ma. Lowes et al., Regression of melanoma, but not keratoacanthoma, is associated with increased HLA-B22 and decreased HLA-B27 and HLA-DR1, MELANOMA RE, 9(6), 1999, pp. 539-544
Citations number
21
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
MELANOMA RESEARCH
ISSN journal
09608931 → ACNP
Volume
9
Issue
6
Year of publication
1999
Pages
539 - 544
Database
ISI
SICI code
0960-8931(199912)9:6<539:ROMBNK>2.0.ZU;2-4
Abstract
Sixty three Caucasian patients with either melanoma, keratoacanthoma or squ amous cell carcinoma were human leucocyte antigen (HLA) typed. The regressi ng tumour groups were compared with their non-regressing counterparts, and the patient groups were compared with a control Caucasian population. Melan oma patients showing histological regression were more likely to be HLA-B22 positive, and HLA-B27 and -DR1 negative, than those without features of re gression. When compared with a control population, the group of melanoma pa tients were more likely to be HLA-B22 positive. Comparison of the group of keratoacanthomas, a self-regressing tumour, and the group of squamous cell carcinomas, a non-regressing tumour, did not show any significant differenc es in HLA typing. (C) 1999 Lippincott Williams & Wilkins.